Literature DB >> 15599216

Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C.

Christopher A Aoki1, Lorenzo Rossaro, Rajendra Ramsamooj, David Brandhagen, Mary F Burritt, Christopher L Bowlus.   

Abstract

PURPOSE: Liver iron is frequently elevated in chronic hepatitis C and may contribute to liver injury. The pathophysiology behind this phenomenon may involve hepcidin, a gene that is up-regulated in the liver by inflammation and iron. Inappropriately low hepcidin is important to the pathophysiology of hereditary hemochromatosis. However, the role of hepcidin in the iron loading of patients with hepatitis C is unknown. SUBJECTS AND METHODS: To determine whether liver hepcidin mRNA correlates with markers of hepatic inflammation and iron status in patients with hepatitis C, we extracted total RNA from liver biopsy specimens of patients with chronic hepatitis C and quantified hepcidin mRNA. Liver hepcidin mRNA levels were then correlated with aspartate aminotransferase, alanine aminotransferase, ferritin, viral load, fibrosis, hepatic iron concentration, and Hepatic Activity Index (HAI).
RESULTS: Among patients with hepatitis C, there was a significant correlation of hepcidin mRNA expression in the liver with hepatic iron concentration and serum ferritin (r = 0.72, P = 0.006, and r = 0.60, P = 0.01, respectively). Hepcidin mRNA expression in the liver did not correlate with aspartate aminotransferase, alanine aminotransferase, HAI, or viral load. No differences in hepcidin mRNA were found based on viral genotype or the presence of fibrosis.
CONCLUSION: In contrast to other inflammatory states, hepcidin mRNA expression in the liver was independent of markers of inflammation in hepatitis C. Instead, our results suggest that iron stores in patients with hepatitis C regulate hepcidin expression and that iron loading in chronic hepatitis C is not due to inappropriate hepcidin expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15599216

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  23 in total

1.  Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.

Authors:  Yoshibumi Kaneko; Hiroaki Miyajima; Alberto Piperno; Naohisa Tomosugi; Hisao Hayashi; Natsuko Morotomi; Ken-ichi Tsuchida; Takaaki Ikeda; Akihisa Ishikawa; Yusuke Ota; Shinya Wakusawa; Kentaro Yoshioka; Satoshi Kono; Sara Pelucchi; Ai Hattori; Yasuaki Tatsumi; Toshihide Okada; Masakazu Yamagishi
Journal:  J Gastroenterol       Date:  2010-06-09       Impact factor: 7.527

2.  Decreased prohepcidin levels in patients with HBV-related liver disease: relation with ferritin levels.

Authors:  Oya Yonal; Filiz Akyuz; Kadir Demir; Sevgi Ciftci; Fahriye Keskin; Binnur Pinarbasi; Ahmet Uyanikoglu; Halim Issever; Sadakat Ozdil; Gungor Boztas; Fatih Besisik; Sabahattin Kaymakoglu; Yilmaz Cakaloglu; Zeynel Mungan; Atilla Okten
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

3.  Iron metabolic disorder in chronic hepatitis C: insights from recent evidence.

Authors:  Keisuke Hino; Sohji Nishina; Yuichi Hara
Journal:  Clin J Gastroenterol       Date:  2012-07-31

4.  The iron homeostasis network and hepatitis C virus - a new challenge in the era of directly acting antivirals.

Authors:  Katarzyna Sikorska
Journal:  Virulence       Date:  2016-05-19       Impact factor: 5.882

5.  A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.

Authors:  Andrew W Tai; Yair Benita; Lee F Peng; Sun-Suk Kim; Naoya Sakamoto; Ramnik J Xavier; Raymond T Chung
Journal:  Cell Host Microbe       Date:  2009-03-19       Impact factor: 21.023

6.  Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications.

Authors:  Hsi-Huang Tseng; Jan-Gowth Chang; Yaw-Huei Hwang; Kun-Tu Yeh; Yao-Li Chen; Hsin-Su Yu
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-23       Impact factor: 4.553

Review 7.  HFE gene in primary and secondary hepatic iron overload.

Authors:  Giada Sebastiani; Ann-P Walker
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 8.  Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.

Authors:  Yutaka Kohgo; Katsuya Ikuta; Takaaki Ohtake; Yoshihiro Torimoto; Junji Kato
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 9.  Role of iron in hepatic fibrosis: one piece in the puzzle.

Authors:  Marie-A Philippe; Richard-G Ruddell; Grant-A Ramm
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

10.  Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C.

Authors:  Naoki Fujita; Ryosuke Sugimoto; Masaki Takeo; Naohito Urawa; Rumi Mifuji; Hideaki Tanaka; Yoshinao Kobayashi; Motoh Iwasa; Shozo Watanabe; Yukihiko Adachi; Masahiko Kaito
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.